Angiographic demarcation of an occlusive lesion may predict recanalization after intra-arterial thrombolysis in patients with acute middle cerebral artery occlusion

Journal of Neuroimaging

Volumn 18, Issue 4, 2008, Pages 422-427

  Otsuka, Yoshinobu ^a,b   Waki, Riichiro ^b   Yamauchi, Hiroshi ^a   Fukazawa, Seiji ^b   Kimura, Kaku ^b   Shimizu, Kotoyuki ^b   Fukuyama, Hidenao ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

Author keywords

Angiographic clot demarcation; Intra arterial thrombolysis; Ischemic stroke; MCA occlusion; Recanalization

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; UROKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EMBOLISM; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL RECORD; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; RECANALIZATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; CAROTID STENOSIS; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 53149154501     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00209.x     Document Type: Article

References (26)

1. NINDS rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 : 1581 1587.
2. The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 : 768 774.
3. Yamaguchi T, Hayakawa T, Kikuchi H, for the Japanese Thrombolysis Study Group. Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 1993 3 : 269 272.
4. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, and the rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiology 1993 14 : 3 13.
5. Saqqur M, Molina CA, Salam A, Siddiqui M, Ribo M, Uchino K, Calleja S, Garami Z, Khan K, Akhtar N, O'Rourke F, Shuaib A, Demchuk AM, Alexandrov AV, and for the CLOTBUST Investigators. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke 2007 38 : 69 74.
6. Ingall TJ, O'Fallon WM, Asplund K, Goldfrank LR, Hertzberg VS, Louis TA, Christianson TJH. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Stroke 2004 35 : 2418 2424.
7. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F, and for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. JAMA 1999 282 : 2003 2011.
8. Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002 33 : 2866 2871.
9. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS, and for the MERCI and Multi MERCI Writing Committee. Mechanical thrombectomy of intracranial internal carotid occlusion. Pooled results of the MERCI and Multi MERCI part I Trials. Stroke 2007 38 : 1274 1280.
10. Mahon BR, Nesbit GM, Barnwell SL, Clark W, Marotta TR, Weill A, Teal PA, Qureshi AI. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003 24 : 534 538.
11. Sauvageau E, Samuelson RM, Levy EI, Jeziorski AM, Mehta RA, Hopkins LN. Middle cerebral artery stenting for acute ischemic stroke after unsuccessful MERCI retrieval. Neurosurgery 2007 60 : 701 706.
12. Pillai JJ, Lanzieri CF, Trinidad SB, Tarr RW, Sunshine JL, Lewin JS. Initial angiographic appearance of intracranial vascular occlusions in acute stroke as a predictor of outcome of thrombolysis: initial experience. Radiology 2001 218 : 733 738.
13. Christoforidis GA, Mohammad Y, Avutu B, Tejada A, Slivka AP. Angiographic demonstration of slow anterograde opacification distal to a cerebrovascular thromboembolic occlusion site as a favorable indicator for intra-arterial thrombolysis. AJNR Am J Neuroradiol 2006 27 : 1528 1531.
14. Qureshi AI, Ali Z, Suri MFK, Kim SH, Shatla AA, Ringer AJ, Lopes DK, Guterman LR, Hopkins LN. Intra-arterial third-generation recombinant tissue plasminogen activator (Reteplase) for acute ischemic stroke. Neurosurgery 2001 49 : 41 50.
15. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III., and the TOAST Investigators. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993 24 : 35 41.
16. Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R. Hemorrhagic transformation of ischemic brain Tissue. Asymptomatic or symptomatic? Stroke 2001 32 : 1330 1335.
17. Arnold M, Nedelchev K, Remonda L, Fischer U, Brekenfeld C, Keserue B, Schroth G, Mattle HP. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical outcome. J Neurol Neurosurg Psychiatry 2005 76 : 1373 1376.
18. Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabín J. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 2004 35 : 486 490.
19. Savitz SI, Schlaug G, Caplan L, Selim M. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005 36 : 1447 1451.
20. Linfante I, Llinas RH, Selim M, Chaves C, Kumar S, Parker RA, Caplan LR, Schlaug G. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002 33 : 2066 2071.
21. Gupta R, Vora NA, Horowitz MB, Tayal AH, Hammer MD, Uchino K, Levy EI, Wechsler LR, Jovin TG. Multimodal reperfusion therapy for acute ischemic stroke. Factors predicting vessel recanalization. Stroke 2006 37 : 986 990.
22. Sabovic M, Lijnen HR, Keber D, Collen D. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators. Thromb Haemostat 1989 62 : 1083 1087.
23. Wu JH, Siddiqui K, Diamond SL. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis. Thromb Haemostat 1994 72 : 105 112.
24. Blinc A, Planinsic G, Keber D, Jarh O, Lahajnar G, Zidensek A, Demsar F. Dependence of blood clot lysis on the mode of transport of urokinase into the clot - a magnetic resonance imaging study in vitro. Thromb Haemostat 1991 65 : 549 552.
25. Blinc A, Keber D, Lahajnar G, Stegnar M, Zidansek A, Demsar F. Lysing patterns of retracted blood clots with diffusion or bulk flow transport of plasma with urokinase into clots-a magnetic resonance imaging study in vitro. Thromb Haemostat 1992 68 : 667 671.
26. Cho KH, Kim JS, Kwon SU, Cho AH, Kang DW. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005 36 : 2379 2383.